473382-39-7 Usage
Description
N3-(7-Cyclobutyl-3-phenyl-1,2,4-triazolo[4,3-b]pyridazin-6-yl)-N1,N1,2,2-tetramethyl-1,3-propanediamine is a complex organic compound with a unique molecular structure that features a cyclobutyl and phenyl group attached to a triazolopyridazine ring. N3-(7-Cyclobutyl-3-phenyl-1,2,4-triazolo[4,3-b]pyridazin-6-yl)-N1,N1,2,2-tetramethyl-1,3-propanediamine is characterized by its amine functional groups, which contribute to its potential reactivity and applications in various fields.
Uses
Used in Pharmaceutical Industry:
N3-(7-Cyclobutyl-3-phenyl-1,2,4-triazolo[4,3-b]pyridazin-6-yl)-N1,N1,2,2-tetramethyl-1,3-propanediamine is used as a pharmaceutical intermediate for the development of novel therapeutic agents. Its unique structure and amine groups make it a promising candidate for the synthesis of drugs targeting specific biological pathways or receptors.
Used in Chemical Research:
In the field of chemical research, this compound serves as a valuable building block for the synthesis of more complex molecules with potential applications in various industries. Its reactivity and structural features can be exploited to create new materials with improved properties.
Used in Cancer Treatment:
N3-(7-Cyclobutyl-3-phenyl-1,2,4-triazolo[4,3-b]pyridazin-6-yl)-N1,N1,2,2-tetramethyl-1,3-propanediamine is used as a research tool in cancer biology to investigate its potential as an anticancer agent. Its ability to modulate specific signaling pathways or interact with cellular targets may provide insights into the development of new cancer therapies.
Used in Drug Delivery Systems:
N3-(7-Cyclobutyl-3-phenyl-1,2,4-triazolo[4,3-b]pyridazin-6-yl)-N1,N1,2,2-tetramethyl-1,3-propanediamine can be utilized in the design of drug delivery systems to improve the efficacy and targeting of therapeutic agents. Its amine groups can be modified to attach drug molecules or used to create prodrugs that are activated upon reaching their target site.
Check Digit Verification of cas no
The CAS Registry Mumber 473382-39-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,3,3,8 and 2 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 473382-39:
(8*4)+(7*7)+(6*3)+(5*3)+(4*8)+(3*2)+(2*3)+(1*9)=167
167 % 10 = 7
So 473382-39-7 is a valid CAS Registry Number.
473382-39-7Relevant articles and documents
Combination therapy
-
, (2008/06/13)
The present invention relates to methods of treating cancer using a combination of at least two Akt inhibitors or a compound which is an inhibitor of Akt and an inhibitor of a protein kinase, which methods comprise administering to a mammal, either sequentially in any order or simultaneously, amounts of at least two therapeutic agents selected from a group consisting of a compound(s) which are inhibitors of Akt and compound(s) which are inhibitors of protein kinases. The invention also relates to methods of preparing such compositions.
